Evaluation of the Safety and Biodistribution Imaging of 68Ga-TRD4425 and Low-Dose ¹77Lu-TRD4425 in Participants with GRPR (+) Solid Tumors

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: d2cff4a1f0ad61ac6900e9abcd256d8e02598f7d
First added on: Oct 10, 2026